‘Asbestos Litigation’ Category

A medical school professor in Australia has teamed up with other scientists to develop a new mesothelioma treatment that reportedly has saved one patient’s life. Dr Glen Reid, an associate professor at the University of Sydney Medical School hopes his ‘groundbreaking’ research can be used to treat the asbestos-related cancer on a widespread scale.

Malignant pleural mesothelioma may soon be getting a new standard of care. Bevacizumab may be added to the current standard chemotherapy regimen of pemetrexed and cisplatin. According to Dr. Gerald Zalcman, who recently presented a paper at the 2015 American Society of Clinical Oncology (ASCO) annual meeting, bevacizumab offers patients with malignant pleural mesothelioma longer survival rates...

Mesothelioma is a health problem for thousands of Americans today because it was so frequently used decades ago as an inexpensive construction material in commercial buildings, as well as other places. Since most of those commercial buildings are still standing, asbestos remains a serious environmental concern.

If a building was...

A clinical trial focused on finding an effective treatment for mesothelioma reportedly is showing encouraging results. The clinical trial involves Defactnib (VS-6063), an Oral Focal Adhesion Kinase Inhibitor developed by the drug maker Verastem, Inc.

The Defactnib clinical trial is now underway in 13...

A recent study from the University of Chicago Medical Center’s Oncology Division of the Department of Surgery reports that mesothelioma patients undergoing aggressive pleurectomy/decortication surgery experience different results, depending on the progression of their disease.

For patients who are diagnosed with mesothelioma at an early stage when symptoms are minimal, the aggressive...

The benefit of immunotherapy for mesothelioma patients is that the treatment uses the body’s own immune system to attack mesothelioma cells without causing injury to healthy cells nearby. In a recently published study of tremelimumab, Italian researchers from the University Hospital of Siena have announced that the drug shows promising results in patients with advanced mesothelioma that has...

Scientists searching for effective treatments for peritoneal mesothelioma are excited about the recent mapping of the genome sequence for the disease. Peritoneal mesothelioma is a fatal cancer of the lining surrounding the abdominal organs. The only confirmed cause of the disease is asbestos exposure.Mesothelioma itself is a rare cancer which strikes 3,000 Americans each year. But most cases...

CRS-207 has been granted orphan drug status by the U. S. Food and Drug Administration (FDA) for treatment of pleural mesothelioma patients. CRS-207, manufactured by Aduro Biotech, had previously been granted orphan drug designation for treatment of pancreatic cancer. The orphan drug designation is made by the FDA’s Office of Orphan Products Development to novel drugs that may help treat or...

Mesothelioma patients whose disease is of the epithelioid subtype may benefit from treatment with a drug that is already being used in patients with large cell lymphoma and Hodgkin’s disease. Adcetris — or brentuximab vedotin — has been shown in encouraging new research to slow the growth of mesothelioma cells containing the protein CD30.

Construction of Nevada highways has been delayed because of the discovery of high levels of asbestos in the soil. Scientists are concerned that the asbestos could be dangerous to residents living nearby. Asbestos exposure is the only confirmed cause of mesothelioma, an incurable cancer of the lining of the lungs and other organs in the body.